India Respiratory Devices Market Size, Trends and Insights By Type (Respiratory Consumables, Nebulizers, Oxygen Concentrators), By End User (Hospitals, Clinics, Ambulatory Surgical Centers), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | India |
| Largest Market: | India |
Major Players
- Philips Healthcare
- ResMed
- Medtronic plc
- Fisher & Paykel Healthcare
- GE Healthcare
- Drägerwerk AG & Co. KGaA
- Others
Reports Description
India Respiratory Devices Market was valued at USD 5.8 Billion in 2024 and is expected to reach USD 9.8 Billion by 2033, at a CAGR of 8.3% during the forecast period 2024 – 2033.
Disposal gowns are one-time protective garments used by healthcare personnel to avoid contamination and the spread of infectious pathogens during medical operations. Typically composed of nonwoven materials such as polypropylene, they are intended to be destroyed after use to maintain hygiene requirements.
India Respiratory Devices Market: Growth Factors
Rising incidence of respiratory disorders
The increased frequency of respiratory illnesses in India is a major driver of the country’s respiratory device industry. Urbanisation, air pollution, tobacco smoking, work dangers, and lifestyle changes all contribute to an increase in the prevalence of respiratory disorders.
As the population grows and urbanisation increases air pollution, respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections become increasingly common. Furthermore, lifestyle changes such as sedentary behaviours, poor food choices, and increased stress levels add to the burden of respiratory disorders.
As a result, there is an increased need for respiratory devices that can effectively control and treat these illnesses. These devices include inhalers and nebulizers for treating acute symptoms, as well as continuous positive airway pressure (CPAP) machines and ventilators for severe cases.
Furthermore, technological improvements have resulted in the creation of novel respiratory devices that increase efficacy, convenience of use, and patient comfort, hence boosting market expansion.
With rising awareness of respiratory health and the availability of a diverse variety of respiratory equipment, the Indian respiratory devices market is likely to expand further to suit the population’s growing healthcare demands.
These devices include inhalers and nebulizers for treating acute symptoms, as well as continuous positive airway pressure (CPAP) machines and ventilators for severe cases. Furthermore, technological improvements have resulted in the creation of novel respiratory devices that increase efficacy, convenience of use, and patient comfort, hence boosting market expansion.
With rising awareness of respiratory health and the availability of a diverse variety of respiratory equipment, the Indian respiratory devices market is likely to expand further to suit the population’s growing healthcare demands. India has 18% of the world’s population yet bears 32% of the worldwide burden of respiratory ailments.
A state-level examination of the Global Burden of Disease statistics revealed that the burden of respiratory disease in India is second only to ischemic heart disease. Chronic respiratory disorders accounted for 10.9% of all fatalities.
Rise in geriatric population
The growing elderly population in India is a major driving force behind the country’s respiratory device industry. As people become older, they become more vulnerable to respiratory problems and chronic illnesses such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia.
The ageing process frequently causes weakening respiratory muscles, decreased lung function, and an increased susceptibility to respiratory infections. Furthermore, age-related illnesses such as arthritis and cardiovascular disease might worsen respiratory problems.
With India’s demographic change to an increasingly senior population, demand for respiratory equipment is likely to rise. These devices serve an important role in controlling respiratory problems in the elderly, providing treatments ranging from inhalers and nebulizers for sudden symptoms to continuous positive airway pressure (CPAP) machines and oxygen therapy devices for chronic illnesses.
Moreover, technological improvements have resulted in the creation of more portable, user-friendly, and effective respiratory equipment designed to meet the special needs of older persons. As India’s senior population grows, so will demand for respiratory equipment, fuelling market expansion.
India Respiratory Devices Market: Restraints
High cost of production
The high production costs are a key obstacle to the expansion of the respiratory devices market in India. This problem is caused by several elements inherent in the production process and the country’s economic situation.
The development of innovative respiratory devices frequently necessitates complex technology, specialized materials, and expert labour, all of which contribute to higher production costs.
India, although making technical advances, nevertheless confronts restrictions in terms of indigenous manufacture of some high-tech components and materials necessary for respiratory devices, resulting in reliance on imports, which raises prices owing to customs, taxes, and logistics.
Furthermore, the severe regulatory requirements and quality standards imposed on medical device makers contribute to the production costs, because compliance involves expenditures in research.
Furthermore, market fragmentation and a large percentage of the population’s relatively low purchasing power limit economies of scale, making it difficult for manufacturers to realise cost savings through bulk manufacturing.
As a result, these variables combine to raise the cost of respiratory equipment, making them less accessible and affordable to a large segment of the Indian population in need, stifling market growth and worsening healthcare disparities.
To address this issue, strategic initiatives such as fostering domestic manufacturing capabilities, incentivizing R&D, streamlining regulatory processes, and promoting public-private partnerships can help drive down production costs, increase market competitiveness, and improve access to respiratory devices for all segments of the population.
India Respiratory Devices Market: Opportunities
AI-driven respiratory devices
AI-powered linked respiratory devices have transformed the landscape of respiratory treatment in India, causing considerable development in the respiratory device industry.
These revolutionary technologies, which seamlessly integrate artificial intelligence algorithms with respiratory devices, provide personalised, real-time monitoring, diagnostic, and treatment options for respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea.
The introduction of AI-powered linked respiratory devices has improved patient outcomes by allowing for remote monitoring and management of respiratory health, particularly in locations with limited access to healthcare facilities.
Furthermore, the devices’ capacity to gather and analyse massive volumes of data on breathing patterns, environmental variables, and treatment reactions provides healthcare practitioners with significant insights for optimising patient care plans.
This data-driven approach not only increases diagnostic speed and accuracy but also allows for preventive treatments to avert exacerbations and problems.
As a result, AI-powered linked respiratory devices have emerged as important growth drivers in the Indian respiratory device market, encouraging increasing use and acceptance of sophisticated respiratory care solutions by both healthcare professionals and patients.
India Respiratory Devices Market: Segmentation Analysis
India Respiratory Devices market is segmented by type, end user and region. Based on type, the market is classified into respiratory consumables, nebulizers, and oxygen concentrators. Oxygen Concentrators dominated the market in 2023 with a market share of 55.3% and are expected to keep their dominance during the forecast period 2024-2033.
Oxygen concentrators have emerged as a key driver in India’s respiratory devices industry, causing substantial development and transformation. These devices serve an important role in administering supplementary oxygen treatment to patients suffering from respiratory illnesses such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory distress syndrome.
India, with its large population and high prevalence of respiratory disorders, has seen an increase in demand for oxygen concentrators, particularly during health emergencies like the COVID-19 pandemic.
Unlike traditional oxygen cylinders, which require regular refilling and pose logistical challenges, oxygen concentrators extract oxygen from ambient air using advanced filtration and concentration technologies, providing a continuous and dependable oxygen supply without the need for frequent replenishment.
Furthermore, the growing desire for home-based care and remote monitoring solutions, fuelled by factors such as rising healthcare costs and an ageing population, has accelerated the use of oxygen concentrators as an essential respiratory treatment solution.
Based on end user, the market is classified into hospitals, clinics, and ambulatory surgical centers. Hospitals dominated the market in 2023 with a market share of 53.1% and are expected to keep their dominance during the forecast period 2024-2033. Hospitals play an important role in driving the respiratory devices market in India because they require modern medical equipment to diagnose, treat, and manage respiratory diseases.
As India faces issues such as air pollution and a rising prevalence of respiratory disorders including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia, hospitals remain the primary site of care for patients seeking respiratory health services.
To accommodate the increased need for respiratory treatment, hospitals invest in a variety of technologies such as ventilators, CPAP machines, nebulizers, oxygen concentrators, and spirometers. These devices are crucial for giving life-saving measures, assisting patients during critical care, and enhancing respiratory function.
Furthermore, the COVID-19 pandemic has highlighted the vital role of respiratory devices in controlling respiratory distress caused by the virus, accelerating the use of these technologies in hospitals across India.
With an increasing emphasis on improving healthcare infrastructure and expanding access to quality medical services, hospitals remain significant drivers of growth in the Indian respiratory devices market, fostering innovation and driving advancements in respiratory care technology to improve patient outcomes and address the population’s changing healthcare needs.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 5.8 Billion |
| Projected Market Size in 2033 | USD 9.8 Billion |
| Market Size in 2023 | USD 5.4 Billion |
| CAGR Growth Rate | 8.3% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Country Scope | India |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
India Respiratory Devices Market: Recent Developments
- In April 2021, ResMed, a global leader in digital health and cloud associated medical devices, expanded AirView for Ventilation, its cloud-based remote management and monitoring platform for respiratory care patients, in India.
- In February 2023, Medtronic opened a new medical facility in Hyderabad with a fresh investment of around USD 300 million.
- In March 2024, GE Healthcare announced a USD 959 million investment in India to boost its medical device manufacturing capacity. The investment, which is planned for the next five years, will see an expansion in the company’s production output as well as domestic R&D.
List of the prominent players in the India Respiratory Devices Market:
- Philips Healthcare
- ResMed
- Medtronic plc
- Fisher & Paykel Healthcare
- GE Healthcare
- Drägerwerk AG & Co. KGaA
- Hamilton Medical
- Masimo Corporation
- Vyaire Medical
- Air Liquide
- Smiths Medical
- Invacare Corporation
- Mindray Medical International Limited
- Becton Dickinson and Company
- Maquet Holding B.V. & Co. KG
- Allied Healthcare Products Inc.
- DeVilbiss Healthcare
- Drive DeVilbiss Healthcare
- Teleflex Incorporated
- Airon Corporation
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The India Respiratory Devices Market is segmented as follows:
By Product Type
- Therapeutic Devices
- Diagnostic & Monitoring Devices
By Therapeutic Devices
- Drug Delivery Devices
- Nebulizers
- Inhalers
- Mechanical Ventilators
- Invasive
- Non-invasive
- Continuous Positive Airway Pressure
- Devices
- Disposables
- Resuscitators
- Reusable
- Disposables
- Humidifiers
- Airway Clearance Devices
- Oxygen Concentrators
- Consumables & Disposables
- Others
By Diagnostic & Monitoring Devices
- Pulse Oximeters
- Capnographs
- Spirometers
- Polysomnographs
- Peak Flow Meters
- Gas Analyzers
- Others
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 India Respiratory Devices Market, (2024 – 2033) (USD Billion)
- 2.2 India Respiratory Devices Market : snapshot
- Chapter 3. India Respiratory Devices Market – Industry Analysis
- 3.1 India Respiratory Devices Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising incidence of respiratory disorders
- 3.2.2 Rise in geriatric population
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Therapeutic Devices
- 3.7.3 Market attractiveness analysis By Diagnostic & Monitoring Devices
- 3.7.4 Market attractiveness analysis By Application
- Chapter 4. India Respiratory Devices Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 India Respiratory Devices Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. India Respiratory Devices Market – Product Type Analysis
- 5.1 India Respiratory Devices Market overview: By Product Type
- 5.1.1 India Respiratory Devices Market share, By Product Type, 2023 and 2033
- 5.2 Therapeutic Devices
- 5.2.1 India Respiratory Devices Market by Therapeutic Devices, 2024 – 2033 (USD Billion)
- 5.3 Diagnostic & Monitoring Devices
- 5.3.1 India Respiratory Devices Market by Diagnostic & Monitoring Devices, 2024 – 2033 (USD Billion)
- 5.1 India Respiratory Devices Market overview: By Product Type
- Chapter 6. India Respiratory Devices Market – Therapeutic Devices Analysis
- 6.1 India Respiratory Devices Market overview: By Therapeutic Devices
- 6.1.1 India Respiratory Devices Market share, By Therapeutic Devices, 2023 and 2033
- 6.2 Drug Delivery Devices
- 6.2.1 India Respiratory Devices Market by Drug Delivery Devices, 2024 – 2033 (USD Billion)
- 6.3 Nebulizers
- 6.3.1 India Respiratory Devices Market by Nebulizers, 2024 – 2033 (USD Billion)
- 6.4 Inhalers
- 6.4.1 India Respiratory Devices Market by Inhalers, 2024 – 2033 (USD Billion)
- 6.5 Mechanical Ventilators
- 6.5.1 India Respiratory Devices Market by Mechanical Ventilators, 2024 – 2033 (USD Billion)
- 6.6 Invasive
- 6.6.1 India Respiratory Devices Market by Invasive, 2024 – 2033 (USD Billion)
- 6.7 Non-invasive
- 6.7.1 India Respiratory Devices Market by Non-invasive, 2024 – 2033 (USD Billion)
- 6.8 Continuous Positive Airway Pressure
- 6.8.1 India Respiratory Devices Market by Continuous Positive Airway Pressure, 2024 – 2033 (USD Billion)
- 6.9 Devices
- 6.9.1 India Respiratory Devices Market by Devices, 2024 – 2033 (USD Billion)
- 6.10 Disposables
- 6.10.1 India Respiratory Devices Market by Disposables, 2024 – 2033 (USD Billion)
- 6.11 Resuscitators
- 6.11.1 India Respiratory Devices Market by Resuscitators, 2024 – 2033 (USD Billion)
- 6.12 Reusable
- 6.12.1 India Respiratory Devices Market by Reusable, 2024 – 2033 (USD Billion)
- 6.13 Disposables
- 6.13.1 India Respiratory Devices Market by Disposables, 2024 – 2033 (USD Billion)
- 6.14 Humidifiers
- 6.14.1 India Respiratory Devices Market by Humidifiers, 2024 – 2033 (USD Billion)
- 6.15 Airway Clearance Devices
- 6.15.1 India Respiratory Devices Market by Airway Clearance Devices, 2024 – 2033 (USD Billion)
- 6.16 Oxygen Concentrators
- 6.16.1 India Respiratory Devices Market by Oxygen Concentrators, 2024 – 2033 (USD Billion)
- 6.17 Consumables & Disposables
- 6.17.1 India Respiratory Devices Market by Consumables & Disposables, 2024 – 2033 (USD Billion)
- 6.18 Others
- 6.18.1 India Respiratory Devices Market by Others, 2024 – 2033 (USD Billion)
- 6.1 India Respiratory Devices Market overview: By Therapeutic Devices
- Chapter 7. India Respiratory Devices Market – Diagnostic & Monitoring Devices Analysis
- 7.1 India Respiratory Devices Market overview: By Diagnostic & Monitoring Devices
- 7.1.1 India Respiratory Devices Market share, By Diagnostic & Monitoring Devices, 2023 and 2033
- 7.2 Pulse Oximeters
- 7.2.1 India Respiratory Devices Market by Pulse Oximeters, 2024 – 2033 (USD Billion)
- 7.3 Capnographs
- 7.3.1 India Respiratory Devices Market by Capnographs, 2024 – 2033 (USD Billion)
- 7.4 Spirometers
- 7.4.1 India Respiratory Devices Market by Spirometers, 2024 – 2033 (USD Billion)
- 7.5 Polysomnographs
- 7.5.1 India Respiratory Devices Market by Polysomnographs, 2024 – 2033 (USD Billion)
- 7.6 Peak Flow Meters
- 7.6.1 India Respiratory Devices Market by Peak Flow Meters, 2024 – 2033 (USD Billion)
- 7.7 Gas Analyzers
- 7.7.1 India Respiratory Devices Market by Gas Analyzers, 2024 – 2033 (USD Billion)
- 7.8 Others
- 7.8.1 India Respiratory Devices Market by Others, 2024 – 2033 (USD Billion)
- 7.1 India Respiratory Devices Market overview: By Diagnostic & Monitoring Devices
- Chapter 8. India Respiratory Devices Market – Application Analysis
- 8.1 India Respiratory Devices Market overview: By Application
- 8.1.1 India Respiratory Devices Market share, By Application, 2023 and 2033
- 8.2 Chronic Obstructive Pulmonary Disease
- 8.2.1 India Respiratory Devices Market by Chronic Obstructive Pulmonary Disease, 2024 – 2033 (USD Billion)
- 8.3 Asthma
- 8.3.1 India Respiratory Devices Market by Asthma, 2024 – 2033 (USD Billion)
- 8.4 Obstructive Sleep Apnea
- 8.4.1 India Respiratory Devices Market by Obstructive Sleep Apnea, 2024 – 2033 (USD Billion)
- 8.5 Respiratory Distress Syndrome
- 8.5.1 India Respiratory Devices Market by Respiratory Distress Syndrome, 2024 – 2033 (USD Billion)
- 8.6 Cystic Fibrosis
- 8.6.1 India Respiratory Devices Market by Cystic Fibrosis, 2024 – 2033 (USD Billion)
- 8.7 Pneumonia
- 8.7.1 India Respiratory Devices Market by Pneumonia, 2024 – 2033 (USD Billion)
- 8.1 India Respiratory Devices Market overview: By Application
- Chapter 9. India Respiratory Devices Market – Regional Analysis
- 9.1 India Respiratory Devices Market Regional Overview
- 9.2 India Respiratory Devices Market Share, by Region, 2023 & 2033 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Philips Healthcare
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 ResMed
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Medtronic plc
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Fisher & Paykel Healthcare
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 GE Healthcare
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Drägerwerk AG & Co. KGaA
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Hamilton Medical
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Masimo Corporation
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Vyaire Medical
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Air Liquide
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Smiths Medical
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Invacare Corporation
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Mindray Medical International Limited
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Becton Dickinson and Company
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Maquet Holding B.V. & Co. KG
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Allied Healthcare Products Inc.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 DeVilbiss Healthcare
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 Drive DeVilbiss Healthcare
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Teleflex Incorporated
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 Airon Corporation
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.21 Others
- 10.21.1 Overview
- 10.21.2 Financials
- 10.21.3 Product Portfolio
- 10.21.4 Business Strategy
- 10.21.5 Recent Developments
- 10.1 Philips Healthcare
List Of Figures
Figures No 1 to 20
List Of Tables
Tables No 1 to 2
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Philips Healthcare
- ResMed
- Medtronic plc
- Fisher & Paykel Healthcare
- GE Healthcare
- Drägerwerk AG & Co. KGaA
- Hamilton Medical
- Masimo Corporation
- Vyaire Medical
- Air Liquide
- Smiths Medical
- Invacare Corporation
- Mindray Medical International Limited
- Becton Dickinson and Company
- Maquet Holding B.V. & Co. KG
- Allied Healthcare Products Inc.
- DeVilbiss Healthcare
- Drive DeVilbiss Healthcare
- Teleflex Incorporated
- Airon Corporation
- Others
FAQs
The restraints of the India Respiratory Devices market is high cost of production.
The major driver for the India Respiratory Devices market is rising incidence of respiratory disorders and rise in geriatric population.
The “Respiratory Consumables” category dominated the market in 2023.
The key players in the market are Philips Healthcare, ResMed, Medtronic plc, Fisher & Paykel Healthcare, GE Healthcare, Drägerwerk AG & Co. KGaA, Hamilton Medical, Masimo Corporation, Vyaire Medical, Air Liquide, Smiths Medical, Invacare Corporation, Mindray Medical International Limited, Becton Dickinson and Company , Maquet Holding B.V. & Co. KG , Allied Healthcare Products Inc., DeVilbiss Healthcare, Drive DeVilbiss Healthcare, Teleflex Incorporated, Airon Corporation, Others.
The market is projected to grow at a CAGR of 8.3% during the forecast period, 2024-2033.
The India Respiratory Devices Market size was valued at USD 5.8 Billion in 2024.